Latest News in the pharma Industry

Biopharma News

Capsugel Extends Inhaled Biotherapeutics Delivery Capability to Phase II Clinical Trials

Capsugel Extends Inhaled Biotherapeutics Delivery Capability to Phase II Clinical Trials

7 May 2015

Read more 
Eleven Biotherapeutics Presents Data on Ocular Therapeutics Pipeline at the ARVO 2015 Annual Meeting

Eleven Biotherapeutics Presents Data on Ocular Therapeutics Pipeline at the ARVO 2015 Annual Meeting

6 May 2015

Read more 
WuXi Biologics Begins Construction of the World's Largest Mammalian Cell Culture Manufacturing Facility Using Disposable Bioreactors

WuXi Biologics Begins Construction of the World's Largest Mammalian Cell Culture Manufacturing Facility Using Disposable Bioreactors

6 May 2015

Read more 
Selvita Establishes its UK Subsidiary in Cambridge

Selvita Establishes its UK Subsidiary in Cambridge

5 May 2015

Read more 
FDA Accepts BLA for Zinbryta (Daclizumab High-Yield Process) For Treatment of MS

FDA Accepts BLA for Zinbryta (Daclizumab High-Yield Process) For Treatment of MS

1 May 2015

Read more 
FDA Accepts sBLA for Opdivo (Nivolumab) in Patients with Previously Untreated Advanced Melanoma

FDA Accepts sBLA for Opdivo (Nivolumab) in Patients with Previously Untreated Advanced Melanoma

30 Apr 2015

Read more 
Positive Phase III Results for Two Antibiotics, Zinforo and Investigational Ceftazidime-Avibactam

Positive Phase III Results for Two Antibiotics, Zinforo and Investigational Ceftazidime-Avibactam

30 Apr 2015

Read more 
Precise and Accurate CHN Data from Low Weight Samples

Precise and Accurate CHN Data from Low Weight Samples

30 Apr 2015

Read more 
Amgen Announces FDA Advisory Committee Meeting to Review Repatha (Evolocumab) as a Treatment for High Cholesterol

Amgen Announces FDA Advisory Committee Meeting to Review Repatha (Evolocumab) as a Treatment for High Cholesterol

29 Apr 2015

Read more 
FDA Grants Priority Review to Boehringer Ingelheim's BLA for Idarucizumab

FDA Grants Priority Review to Boehringer Ingelheim's BLA for Idarucizumab

24 Apr 2015

Read more 
New Customized Fluid Transfer Service Simplifies the Biopharmaceutical Manufacturing Process

New Customized Fluid Transfer Service Simplifies the Biopharmaceutical Manufacturing Process

22 Apr 2015

Read more 
Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore

Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore

20 Apr 2015

Read more